People using weight loss medication have been told it's not a "quick fix" with many at risk of regaining their lost weight.

Hims & Hers delivered strong Q2 growth, driven by compounded GLP-1 offerings, but faces uncertainty as regulatory and supply ...

Patients ending obesity medication or finishing a weight management programme should be offered support to help keep the ...